173 related articles for article (PubMed ID: 7592217)
1. ATP-sensitive K+ channels are not involved in ischemia-reperfusion lung endothelial injury.
Khimenko PL; Moore TM; Taylor AE
J Appl Physiol (1985); 1995 Aug; 79(2):554-9. PubMed ID: 7592217
[TBL] [Abstract][Full Text] [Related]
2. Adenosine A2 receptors reverse ischemia-reperfusion lung injury independent of beta-receptors.
Khimenko PL; Moore TM; Hill LW; Wilson PS; Coleman S; Rizzo A; Taylor AE
J Appl Physiol (1985); 1995 Mar; 78(3):990-6. PubMed ID: 7775345
[TBL] [Abstract][Full Text] [Related]
3. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.
Docherty JC; Gunter HE; Kuzio B; Shoemaker L; Yang L; Deslauriers R
J Mol Cell Cardiol; 1997 Jun; 29(6):1665-73. PubMed ID: 9220352
[TBL] [Abstract][Full Text] [Related]
4. Lack of a pharmacologic interaction between ATP-sensitive potassium channels and adenosine A1 receptors in ischemic rat hearts.
Grover GJ; Baird AJ; Sleph PG
Cardiovasc Res; 1996 Apr; 31(4):511-7. PubMed ID: 8689642
[TBL] [Abstract][Full Text] [Related]
5. Activation of ATP-sensitive K+ channels by cromakalim. Effects on cellular K+ loss and cardiac function in ischemic and reperfused mammalian ventricle.
Venkatesh N; Stuart JS; Lamp ST; Alexander LD; Weiss JN
Circ Res; 1992 Dec; 71(6):1324-33. PubMed ID: 1423930
[TBL] [Abstract][Full Text] [Related]
6. KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide.
Ferdinandy P; Szilvássy Z; Droy-Lefaix MT; Tarrade T; Koltai M
Cardiovasc Res; 1995 Nov; 30(5):781-7. PubMed ID: 8595627
[TBL] [Abstract][Full Text] [Related]
7. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts.
Tosaki A; Hellegouarch A
J Am Coll Cardiol; 1994 Feb; 23(2):487-96. PubMed ID: 8294705
[TBL] [Abstract][Full Text] [Related]
8. ATP-dependent K+ channels in renal ischemia reperfusion injury.
Rahgozar M; Willgoss DA; Gobé GC; Endre ZH
Ren Fail; 2003 Nov; 25(6):885-96. PubMed ID: 14669848
[TBL] [Abstract][Full Text] [Related]
9. Effects of cromakalim and glibenclamide on arteriolar and venular diameters and macromolecular leakage in the microcirculation during ischemia/reperfusion.
Simões C; Svensjö E; Bouskela E
J Cardiovasc Pharmacol; 2002 Mar; 39(3):340-6. PubMed ID: 11862112
[TBL] [Abstract][Full Text] [Related]
10. ATP-sensitive potassium channels in smooth muscle cells from guinea pig urinary bladder.
Bonev AD; Nelson MT
Am J Physiol; 1993 May; 264(5 Pt 1):C1190-200. PubMed ID: 8498480
[TBL] [Abstract][Full Text] [Related]
11. Analysis of pulmonary and systemic vascular responses to cromakalim, an activator of K+ATP channels.
Minkes RK; Kvamme P; Higuera TR; Nossaman BD; Kadowitz PJ
Am J Physiol; 1991 Mar; 260(3 Pt 2):H957-66. PubMed ID: 1825747
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of protection afforded by preconditioning to endothelial function against ischemic injury.
Bouchard JF; Lamontagne D
Am J Physiol; 1996 Nov; 271(5 Pt 2):H1801-6. PubMed ID: 8945894
[TBL] [Abstract][Full Text] [Related]
13. Ischemic cardioprotection by ATP-sensitive K+ channels involves high-energy phosphate preservation.
McPherson CD; Pierce GN; Cole WC
Am J Physiol; 1993 Nov; 265(5 Pt 2):H1809-18. PubMed ID: 8238595
[TBL] [Abstract][Full Text] [Related]
14. Role of calmodulin and myosin light-chain kinase in lung ischemia-reperfusion injury.
Khimenko PL; Moore TM; Wilson PS; Taylor AE
Am J Physiol; 1996 Jul; 271(1 Pt 1):L121-5. PubMed ID: 8760141
[TBL] [Abstract][Full Text] [Related]
15. Effects of glibenclamide on the regional haemodynamic actions of alpha-trinositol and its influence on responses to vasodilators in conscious rats.
Gardiner SM; Kemp PA; March JE; Fallgren B; Bennett T
Br J Pharmacol; 1996 Feb; 117(3):507-515. PubMed ID: 8821541
[TBL] [Abstract][Full Text] [Related]
16. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
Tosaki A; Szerdahelyi P; Engelman RM; Das DK
J Pharmacol Exp Ther; 1993 Dec; 267(3):1355-62. PubMed ID: 8263798
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological evidence for the persistent activation of ATP-sensitive K+ channels in early phase of reperfusion and its protective role against myocardial stunning.
Shigematsu S; Sato T; Abe T; Saikawa T; Sakata T; Arita M
Circulation; 1995 Oct; 92(8):2266-75. PubMed ID: 7554211
[TBL] [Abstract][Full Text] [Related]
18. Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels.
Cavero I; Mondot S; Mestre M
J Pharmacol Exp Ther; 1989 Mar; 248(3):1261-8. PubMed ID: 2495353
[TBL] [Abstract][Full Text] [Related]
19. Effects of ATP-dependent K+ channel modulators on an ischemia-reperfusion rabbit isolated heart model with programmed electrical stimulation.
Bellemin-Baurreau J; Poizot A; Hicks PE; Rochette L; Armstrong JM
Eur J Pharmacol; 1994 Apr; 256(2):115-24. PubMed ID: 8050462
[TBL] [Abstract][Full Text] [Related]
20. The involvement of ATP-sensitive potassium channels and adenosine in the regulation of coronary flow in the isolated perfused rat heart.
Randall MD
Br J Pharmacol; 1995 Dec; 116(7):3068-74. PubMed ID: 8680745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
